Your browser doesn't support javascript.
loading
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia.
Alghamdi, Ahlam; Alsanea, Nasser; Alraey, Mohammed; Joseph, Mercy; Aboud, Mohammed; Almangour, Thamer; Alharbi, Wasaef; Alhumidan, Hind; Alanizi, Abdalrhman; Al-Jedai, Ahmed.
Afiliación
  • Alghamdi A; From the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Alsanea N; From the Department of Pharmacy, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Alraey M; From the Department of Surgery, Alfaisal University, King Faisal Specialist Hospital and Research Centre, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Joseph M; From the Infectious Diseases Department, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Aboud M; From the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Almangour T; From the Infectious Diseases Department, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Alharbi W; From the Department of Pharmacy, King Abdullah bin Abdulaziz Unviversity Hospital, Riyadh, Saudi Arabia.
  • Alhumidan H; From the Department of Pathology and Laboratory Medicine, King Abdullah bin Abdulaziz Unviversity Hospital, Riyadh, Saudi Arabia.
  • Alanizi A; From the Department of Pathology and Laboratory Medicine, King Abdullah bin Abdulaziz Unviversity Hospital, Riyadh, Saudi Arabia.
  • Al-Jedai A; From the Department of Pharmacy, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
Ann Saudi Med ; 42(4): 223-228, 2022.
Article en En | MEDLINE | ID: mdl-35933607
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Newborn País/Región como asunto: Asia Idioma: En Revista: Ann Saudi Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Newborn País/Región como asunto: Asia Idioma: En Revista: Ann Saudi Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita